Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma, Adult”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00003530
What this trial is testing

Antineoplaston Therapy in Treating Patients With Primary Liver Cancer

Who this might be right for
Primary Liver Cancer
Burzynski Research Institute 3
Not applicableNo Longer AvailableNCT00589030
What this trial is testing

Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00003557
What this trial is testing

Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
University of Chicago 16
Testing effectiveness (Phase 2)Study completedNCT00006006
What this trial is testing

Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed

Who this might be right for
Liver Cancer
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)WithdrawnNCT00093548
What this trial is testing

Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer

Who this might be right for
Liver Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04567615
What this trial is testing

Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors

Who this might be right for
Hepatocellular CarcinomaHepatomaLiver Cancer, Adult+2 more
Bristol-Myers Squibb 266
Early research (Phase 1)Study completedNCT00844168
What this trial is testing

Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Resectable Adult Primary Liver Cancer+2 more
University of Washington 4
Early research (Phase 1)Study completedNCT01011010
What this trial is testing

Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver Cancer
UNC Lineberger Comprehensive Cancer Center 11
Large-scale testing (Phase 3)Study completedNCT00012324
What this trial is testing

Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer

Who this might be right for
Liver Cancer
Eximias Pharmaceutical
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00027534
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerGallbladder Cancer+6 more
Michael Morse, MD 14
Testing effectiveness (Phase 2)Ended earlyNCT00787787
What this trial is testing

Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
University of Washington 41
Early research (Phase 1)Study completedNCT02578602
What this trial is testing

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage 0 Adult Hepatocellular Carcinoma+6 more
University of Southern California 26
Large-scale testing (Phase 3)Study completedNCT00003424
What this trial is testing

Tamoxifen in Treating Patients With Primary Liver Cancer

Who this might be right for
Liver Cancer
National Medical Research Council (NMRC), Singapore 300
Testing effectiveness (Phase 2)Study completedNCT00513461
What this trial is testing

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

Who this might be right for
Adult Primary Liver CancerHepatitis C Infection
Chao Family Comprehensive Cancer Center 110
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT02024087
What this trial is testing

Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Adult Hepatocellular Carcinoma
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 21
Early research (Phase 1)Looking for participantsNCT06858813
What this trial is testing

Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

Who this might be right for
Hepatocellular CancerSquamous-Cell Non-Small Cell Lung Cancer
AbbVie 232
Testing effectiveness (Phase 2)Study completedNCT01356628
What this trial is testing

A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaHCCLiver Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 23
Not applicableWithdrawnNCT00899002
What this trial is testing

Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer

Who this might be right for
Liver Cancer
Vanderbilt-Ingram Cancer Center
Next Page